Liking, wanting, and craving cannabis come from genetics, stress vulnerability, and the desire to "treat" depression, anxiety ...

To scale in an era of interstate commerce, the cannabis industry needs to return to classic heirloom genetics, our guest columnist writes.

Donald Trump’s reclassification of marijuana was welcome news to many, writes Armstrong Williams, but it won’t make America ...

Down almost 70% from all-time highs, Curaleaf is a TSX cannabis stock that trades at an attractive valuation in December 2025 ...

MIAMI, FLORIDA / ACCESS Newswire / December 19, 2025 / Remergify, the preeminent leader in corporate resurrection and asset revitalization for dormant and undervalued public companies, today announced ...

We ran rats through this extensive battery of behavioral and biological tests, and what we found was that when we look at all ...

Once cannabis has hijacked the reward center, daily users have no destination in mind. Here's how parents maintain empathy for an addicted child.

Down almost 70% from all-time highs, Curaleaf stock offers significant upside potential given its widening free cash flow ...

Federal reform, if it lands as expected, is not the "green light" many traders are pricing. It is the beginning of ...

Less than 30% of people with certain genetic variants go blind, despite the faulty genes previously being thought to cause ...

President Trump is expected to sign an executive order that could reclassify marijuana from a Schedule I to a Schedule III ...